Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Bioprocessing - Upstream & Downstream

Manufacture Bioprocessing - Upstream & Downstream

A Grueling Environment

| Phil Williams

NASA ultimately wants to send humans to Mars – and those humans will need medicines.

Manufacture Technology and Equipment

The Astropharmacy Concept

| Stephanie Sutton

How do we make medicines in space? Lynn J. Rothschild explains how biologic medicines can be made on demand.

Manufacture Bioprocessing - Upstream & Downstream

Fighting Viruses with Enhanced ADCC

| Andrew J Racher

Researchers are always looking for new ways to improve effectiveness of antibody therapy.

Manufacture Bioprocessing - Single Use Systems

The Power List 2021: Nominate Now

| Stephanie Sutton

Nominations are now open for The Medicine Maker 2021 Power List.

Manufacture Bioprocessing - Single Use Systems

Charting the Rise of Single Use

| Stephanie Sutton

Single-use systems have come a long way. We look at experience with the technology so far.

Manufacture Quality & Compliance

Zero Defects

| Massimo Mainetti

Lives and livelihoods depend on accelerating large molecule drug production, so biopharma companies must minimize defects and contamination.

Manufacture Technology and Equipment

The Innovation Awards 2020

In December, The Medicine Maker will showcase the top technologies to have been released throughout 2020. Nominations are now open.

Manufacture Bioprocessing - Upstream & Downstream

Glass Matters

| Stephanie Sutton

The Medicine Maker 2019 Innovation Awards included Schott’s Everic glass vials as a deserved runner up.

Manufacture Advanced Medicine

The Beauty of the Box

| Stephanie Sutton

Cytiva’s KUBio box modular environment for Viral Vectors took the top spot in The Medicine Maker 2019 Innovation Awards. Find out why.

Manufacture Advanced Medicine

Optimizing AAV Manufacture

| Orjana Terova, Zoltan Gulyas

Gene therapies look set to revolutionize the field of medicine – and AAVs have emerged as the vector of choice.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register